Compare TELA & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TELA | MLCI |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | 21 |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3M | 37.6M |
| IPO Year | 2019 | N/A |
| Metric | TELA | MLCI |
|---|---|---|
| Price | $0.70 | $3.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 51.2K | 21.5K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ 37.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,275,000.00 | N/A |
| Revenue This Year | $10.23 | N/A |
| Revenue Next Year | $14.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $2.68 |
| 52 Week High | $2.14 | $8.68 |
| Indicator | TELA | MLCI |
|---|---|---|
| Relative Strength Index (RSI) | 41.34 | 43.07 |
| Support Level | $0.67 | $2.70 |
| Resistance Level | $0.75 | $3.61 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 1.02 | 0.00 |
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The company's reporting segments include asset management and insurance. The company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The Asset Management segment comprises all fee generating activities. The Insurance Solutions segment, which derives maximum revenue, consists of two product lines within the insurance business, LTC and MYGA.